SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF

Bibliographic Details
Main Authors:	Davies, J, Davies, G, Gill, D, Hyde, S, Boyd, C, Innes, J, Porteous, D, Cheng, S, Scheule, R, Higgins, T, Griesenbach, U, Alton, E
Format:	Journal article
Published:	2011

Similar Items

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
by: Davies, J, et al.
Published: (2009)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
by: Griesenbach, U, et al.
Published: (2011)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
by: Alton, E, et al.
Published: (2012)

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF
by: Alton, E, et al.
Published: (2013)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
by: Davies, J, et al.
Published: (2009)

Self-reactive CFTR T cells in humans: implications for gene therapy.
by: Calcedo, R, et al.
Published: (2013)

Delivery of genes into the CF airway
by: Gill, D, et al.
Published: (2014)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
by: Gill, DR, et al.
Published: (2010)

Genetic medicines for CF: Hype versus reality
by: Alton, E, et al.
Published: (2016)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
by: Alton, E, et al.
Published: (2012)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
by: Alton, E, et al.
Published: (2012)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
by: Alton, E, et al.
Published: (2012)

Assessment of CFTR function after gene transfer in vitro and in vivo.
by: Griesenbach, U, et al.
Published: (2008)

Sendai virus-mediated CFTR gene transfer to the airway epithelium.
by: Ferrari, S, et al.
Published: (2007)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
by: Alton, E, et al.
Published: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
by: Alton, E, et al.
Published: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
by: Alton, E, et al.
Published: (2014)

Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy.
by: Broackes-Carter, F, et al.
Published: (2002)

Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity.
by: Holder, E, et al.
Published: (2010)

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2015)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
by: Davies, L, et al.
Published: (2008)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
by: Hyde, S, et al.
Published: (2015)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

UKCF gene therapy consortium tracking study: Sputum and serum calprotectin are useful novel measurements in CF exacerbation
by: Gray, R, et al.
Published: (2007)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
by: Davidson, H, et al.
Published: (2008)

An immunocytochemical assay to detect human CFTR expression following gene transfer.
by: Davidson, H, et al.
Published: (2009)

EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN PATIENTS WITH CF: DATA FROM THE UK CF GENE THERAPY CONSORTIUM (UKCFGTC) 'RUN-IN' STUDY
by: Saunders, C, et al.
Published: (2010)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
by: Alton, E, et al.
Published: (2013)

The upper and lower airway microbiome in severe asthma
by: Jabeen, M, et al.
Published: (2022)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY
by: Alton, E, et al.
Published: (2010)

Plasmid Inhalation: Delivery to the Airways
by: Davies, L, et al.
Published: (2006)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY
by: Alton, E, et al.
Published: (2010)

A revised airway epithelial hierarchy includes CFTR-expressing ionocytes
by: Regev, Aviv
Published: (2020)

Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
by: Griesenbach, U, et al.
Published: (2006)

Moving lentiviral-based gene therapy into a first-in-man CF trial
by: Griesenbach, D, et al.
Published: (2015)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
by: Alton, E, et al.
Published: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
by: Alton, E, et al.
Published: (2013)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
by: Sergijenko, A, et al.
Published: (2021)